Bloomage BioTechnology Corporation Limited (SHA:688363)

Market Cap	23.73B
Revenue (ttm)	5.37B
Net Income (ttm)	164.32M
Shares Out	478.36M
EPS (ttm)	0.34
PE Ratio	145.88
Forward PE	36.51
Dividend	0.38 (0.77%)
Ex-Dividend Date	Aug 8, 2024

Volume	2,259,950
Average Volume	3,975,153
Open	50.28
Previous Close	50.45
Day's Range	49.51 - 50.83
52-Week Range	44.72 - 84.59
Beta	0.91
RSI	46.00
Earnings Date	Apr 11, 2025

About SHA:688363

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under th...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2000
• Employees: 4,655
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688363

Financial Performance

In 2024, SHA:688363's revenue was 5.37 billion, a decrease of -11.60% compared to the previous year's 6.08 billion. Earnings were 164.32 million, a decrease of -72.27%.